Nanome Inc

https://nanome.ai/

Nanome develops collaborative and immersive tools for enterprise drug discovery. Nanome’s software is used by early stage R&D teams from pharmaceutical and biotechnology companies to develop new drugs. The software has native collaboration and integrates with 3rd party simulation software. Nanome has published a paper with Novartis GNF in the journal of molecular modelling.

Company Info:

Year Founded:
2015

Founders:
Sam Hessenauer, Steve McCloskey, Keita Funakawa, Edgardo Leija

CEO(s)/CTO(s)/Other Officers:
Steve McCloskey CEO, Sam Hessenauer Chief Engineer, Keita Funakawa COO

Investors:
Colopl Next, HTC, angels

Company Size:
11 to 20

Stage:
Seed (must be over 1M)